Serotonergic neurotransmission is involved in the regulation
Introduction
Central serotonin ] function has a profound role in the normal brain function, in which it modulates mood, sex, appetite, sleep, memory, emotion, and endocrine responses. Serotonin is synthesized and released by neurons that have their cell bodies in the raphe nuclei in the brainstem, and the effect of its release is mediated through at least 15 presynaptic and postsynaptic receptors.
The presynaptically located serotonin transporter (SERT) is crucial for the regulation of 5-HT transmission because it controls the 5-HT availability at the site of the postsynaptic receptors by high-affinity reuptake of released 5-HT (Blakely et al., 1994) . The SERT protein is expressed in high density in dorsal and median raphe nuclei, caudate, putamen, and thalamus but in relatively low densities in cortex (Varnas et al., 2004) . More specifically, SERTs are localized on cell bodies in the raphe nucleus as well as on serotonergic axons and nerve terminals (Zhou et al., 1998 (Zhou et al., , 2000 .
The 5-HT neurotransmission is mediated through different postsynaptic receptors such as the 5-HT 2A . This receptor is heterogeneously distributed with high receptor concentrations in several cortical areas (Pazos et al., 1987; Adams et al., 2004; Varnas et al., 2004) in which they are located primarily postsynaptically (and perisynaptically) (Miner et al., 2003) . The cerebral 5-HT 2A receptors are mainly expressed on glutamatergic pyramidal neurons, cholinergic neurons, and GABAergic interneurons (Morilak et al., 1994; Santana et al., 2004) , and, in most areas of the forebrain, regional variations in their density correspond closely to the 5-HT axon innervation (Blue et al., 1988) .
Cerebral 5-HT 2A receptors and SERT protein levels both respond to chronic changes in 5-HT levels. In vitro autoradiography and homogenate binding experiments in rats suggest that a decrease in SERT binding levels occur after pharmacologically induced chronic extracellular 5-HT depletion in two (Rattray et al., 1996; Rothman et al., 2003) of three studies (no change seen in the study by Dewar et al., 1992) . Chronically elevated extracellular 5-HT levels have usually been achieved by chronic treatment with the specific selective serotonin reuptake inhibitor (SSRI) compounds sertraline, citalopram, and paroxetine, and, in 10 ( Kovachich et al., 1992; Pineyro et al., 1994; Benmansour et al., 1999; Horschitz et al., 2001; Benmansour et al., 2002; Gould et al., 2003 Gould et al., , 2006 Rossi et al., 2008) of 15 experimental settings (no change reported in the studies by Graham et al., 1987; Kovachich et al., 1992; Cheetham et al., 1993; Gobbi et al., 1997; Gould et al., 2006) , decreased SERT levels have been found. It can be argued, however, that chronic blockade of the SERT may lead to regulation of its expression and that the primary cause for the SERT downregulation is unrelated to 5-HT levels. However, support for a direct 5-HT effect comes from monoamine oxidase A knock-out mice. These mice have increased extracellular 5-HT levels and reduced SERT levels (Evrard et al., 2002) . For the 5-HT 2A receptors, moderate 5-HT depletion results in an inverse correlation between 5-HT and 5-HT 2A receptor levels (Heal et al., 1985; Cahir et al., 2007) , and chronically increased 5-HT levels after SSRI treatment results in a reduction in 5-HT 2A receptor binding (Nelson et al., 1989; Cowen, 1990; Maj et al., 1996; Gunther et al., 2008; Licht et al., 2009) . The latter observation has also been made in humans; chronic (Spigset and Mjorndal, 1997; Meyer et al., 2001) but not acute ) SSRI treatment decreases cortical 5-HT 2A receptor binding. Likewise, acute tryptophan depletion in humans, resulting in a transient reduction in cerebral 5-HT levels, does not alter cerebral SERT binding (Praschak-Rieder et al., 2004 Talbot et al., 2005) . In the absence of competition effects, it is unlikely that acutely induced alterations in cerebral 5-HT levels alone would lead to immediate changes in SERT binding as assessed with in vivo imaging. Protein expression and trafficking are considered to be more long-term processes, and, accordingly, Ͼ5 d of 5-HT depletion is required to see a downregulation in SERT binding (Rattray et al., 1996) .
The aim of this study was, for the first time, to investigate the in vivo relationship between SERT and 5-HT 2A receptor binding in a large group of healthy human subjects using the selective positron emission tomography (PET) radioligands [ Provided that in normal healthy individuals there is some interindividual variation in the dorsal raphe output and because both 5-HT 2A receptors and SERT protein levels are sensitive to a common regulating factor in terms of chronic changes in cerebral 5-HT levels, it was the expectation that 5-HT 2A receptors and SERT protein levels each show a within-subject interregional correlation and that the two markers are correlated. More specifically, we hypothesized, first, that a high degree of covariation between brain regions was present for both SERT and 5-HT 2A receptors and, second, that the relationship between [ 
Materials and Methods
Participants and interviews. Fifty-six adult human subjects were included in the study. The mean age was 36 Ϯ 19 years (range, 20 -82 years); 22 were females, and 34 were males. Written informed consent was obtained according to the Declaration of Helsinki II, and the study had been approved by the local ethics committee (KF 02-058/99, KF 12-122/99, KF 12-113/00, KF 12-152/01, KF 01-001/02, KF 11-061/03 and KF 12-142/ 03, KF 01-124/04, KF 01-156/04, KF 01 2006-20) . All subjects were screened for medical history, had a normal neurological examination, and were lifetime naive for antipsychotics and antidepressants. None of the subjects had stimulant abuse or history of neurological or psychiatric disorders.
PET imaging. All subjects were PET scanned with both [ 11 C]DASB and [
18 F]altanserin on an 18-ring GE-Advance scanner (GE Healthcare) operating in three-dimensional acquisition mode producing 35 image slices with an interslice distance of 4.25 mm. The total axial field of view was 15.2 cm with an approximate in-plane resolution of down to 5 mm. Reconstruction, attenuation, and scatter correction procedures were conducted according to DeGrado et al. (1994) . All subjects were scanned in a resting state.
For [ 18 F]altanserin, subjects underwent a 40 min scan under tracer steady-state conditions as described by Pinborg et al. (2003) (Pinborg et al., 2003) . In steady state, BP P is defined as follows:
where C VOI and C ND are steady-state mean count density in the volume of interest (VOI) and in the reference region, respectively, C P is the steady-state activity of nonmetabolized tracer in plasma, f P is the free fraction of radiotracer, B max is the density of receptor sites available for tracer binding, and K d is the affinity constant of the radiotracer to the receptor. ) and ), respectively.
Magnetic resonance imaging. Magnetic resonance imaging (MRI) of the brain was acquired on a Siemens Magnetom Trio 3 T MR scanner with an eight-channel head coil (In Vivo Clinical Research). Highresolution three-dimensional T1-weighted, sagittal, magnetization prepared rapid gradient echo scans of the head and T2-weighted scans of the whole brain were acquired. Both T1 and T2 images were corrected for spatial distortions because of nonlinearity in the gradient system if the scanner (Jovicich et al., 2006) using the Gradient Non-Linearity Distortion Correction software distributed by the Biomedical Informatics Research Network (http://www.nbirn.net). Subsequently, non-uniformity correction of the T1 images was performed with two iterations of the N3 program (Sled et al., 1998) . The resulting T1 images were intensity normalized to a mean value of 1000. To enable extraction of the PET VOI signal from gray matter voxels only, MR images were segmented into gray matter, white matter, and CSF tissue classes using SPM2 (Welcome Department of Cognitive Neurology, University College London, UK) and the hidden Markov random field model as implemented in the SPM2 VBM toolbox (http://dbm.neuro.uni-jena.de/vbm/). This was done for the subcortical high-binding region and for neocortex but not for midbrain because the segmentation within this region is not considered reliable. Therefore, all midbrain voxels were included in the analysis. A brain mask based on the gradient nonlinearity corrected T2 image was used to exclude extracerebral tissue.
Volumes of interest. VOIs were automatically delineated on each individual's transaxial MRI slices in a strictly user-independent manner . With this approach, a template set of 10 MRIs is automatically coregistered to a new subject's MR image. The identified transformation parameters are used to define VOIs in the new subject MRI space, and, through the coregistering, these VOIs are transferred onto the PET images.
For both the SERT and 5-HT 2A receptor, we computed an average binding potential for neocortex for each subject, and this served as the primary outcome. This region consisted of a volume-weighted average of eight cortical regions (orbitofrontal cortex, medial inferior frontal cortex, superior frontal cortex, superior temporal cortex, medial inferior temporal cortex, sensory motor cortex, parietal cortex, and occipital cortex). In addition, for SERT binding, the midbrain and a subcortical highbinding region consisting of a volume-weighted average of caudate, putamen, and thalamus were defined. The cerebellum, except the vermis, was defined and used for nonspecific binding measurements for both markers because this region has only negligible amounts of 5-HT 2A receptors and SERT (Pazos et al., 1987; Cortés et al., 1988; Kish et al., 2005) .
Statistics. For both measurements, the correlation structure between regions was assessed, and graphical representations of the correlation matrices (Murdoch and Chow, 1996) were presented. Furthermore, a principal component analysis was performed as an explorative analysis of the inter-regional variation for both markers.
To explore the association between 5-HT 2A receptor binding (BP P ) in neocortex and SERT binding (BP ND ) in midbrain, caudate-putamenthalamus (subcortical high-binding region), and neocortex, respectively, a nonparametric model using penalized regression splines with the smoothness automatically selected by a generalized cross-validation criterion (Wood, 2008 ) was first applied.
We aimed for a parametric model allowing for an easier interpretation. Based on a nonparametric regression analysis, the association between the two markers was subsequently modeled using up to an order of three polynomials of the 5-HT 2A BP P . The subsequent model selection was based on Akaike's information criterion (AIC), for which all three regional relationships was in favor of a quadratic expression.
To address potential confounding effects of (1) a long time period between measurements of the two markers and (2) the relatively few included subjects with very high 5-HT 2A receptor binding, the quadratic effect was estimated post hoc in two different subsamples: one subsample of subjects with a maximum 2 week interval between the two measurements, and one subsample in which subjects with high 5-HT 2A BP P were omitted (the five largest 5-HT 2A BP P values corresponding to a cutoff point at the 90% quantile).
Results
For the 56 healthy individuals, the average neocortical [ Graphical representations of the inter-regional correlation matrices (Murdoch and Chow, 1996) are shown in Figure 1 . They reveal high pairwise correlations between regions. The interregional correlation was most pronounced in the 5-HT 2A marker (Fig. 1a) in which the principal component analysis revealed a first principal component, with the distinctive features being global changes in the 5-HT 2A level (i.e., a random intercept) and accounting for 80% of the total variation in the dataset.
The estimated shape of the curve with pointwise approximate 95% confidence limits from the nonparametric analysis are presented in Figure 2a -c. Based on this explorative analysis and in agreement with the previously mentioned experimental results, an inverted U-shaped relationship between SERT and 5-HT 2A receptor binding seems reasonable. The estimated quadratic association between cortical 5-HT 2A receptor binding and cortical and subcortical SERT binding are presented in Figure 2d -f together with the estimated curves in the subsample of individuals with Ͻ2 weeks separating the two measurements. The p values for the second-order term in the model were 0.0045, 0.0003, and 0.0836 for the association between the 5-HT 2A receptor binding in neocortex and the SERT binding in the subcortical highbinding region, neocortex, and in midbrain, respectively. Although the relationship in the midbrain was only borderline significant, the AIC was still in favor of the quadratic model in this region. Including an interaction term in the main model with the grouping defined by more or less than 2 weeks between measurements, we did not find any significant differences in the shape of the curves between the two groups. The quadratic relation between the two markers was also seen for two of three of the investigated relations in the subset of individuals excluding the top 10% 5-HT 2A BP P values, but the relationship was no longer statistically significant in midbrain SERT versus cortical 5-HT 2A .
Discussion
This is the first study to directly compare the cerebral in vivo binding of the 5-HT 2A receptor and the SERT in the same healthy individuals. In our sample of 56 healthy people, we found a high degree of covariation in the regional brain density of both A high degree of covariation in [ 18 F]altanserin binding was found, accounting for 80% of the total variation in the dataset and was particularly pronounced across the cortical brain regions. We are unaware of other studies having addressed statistically the issue of covariation in receptor/transporter binding between regions within the same individual. When examining global effects, our finding supports the use of a single outcome parameter, in this case the volumeweighted average cortical 5-HT 2A receptor BP P . We noted that, for the subcortical brain structures caudate nucleus, putamen, hypothalamus, and thalamus, the intercorrelation in BP P was somewhat smaller, although a tendency for an intercorrelation was almost invariably seen. In the subcortical structures, the density of 5-HT 2A receptors is low. Therefore, it should be considered whether the lower covariation in these regions is caused by increased noise levels. There is for [ 11 C]DASB, however, less covariation in the subcortical regions than in cortex, despite a low cortical SERT binding. One possible explanation is that receptors and transporters in brain regions receiving projections from the different subgroups of serotonergic neurons in the midbrain vary in their response to serotonergic activity. It is known that neurons in the dorsomedial and the ventral, paramedian part of the dorsal raphe nucleus account for the vast majority of mesostriatal 5-HT projections (Lowry, 2002) . It might be that the regulation of receptors/transporters of these neurons and those in their projection areas is independent from the regulation of markers on other projections.
Although often implicitly inferred, 5-HT 2A binding levels are occasionally interpreted as reflecting cerebral 5-HT levels, with high 5-HT levels resulting in lower 5-HT 2A receptor binding and vice versa (Adams et al., 2005; Haugbøl et al., 2007; Meyer, 2007) . This interpretation is in accordance with our observation of a high interregional correlation of 5-HT 2A receptor binding, which is suggestive of a common regulator, presumably the raphe serotonergic output. Given that the 5-HT 2A receptor binding is accepted as a surrogate marker of cerebral 5-HT levels and that SERT binding adjusts to 5-HT levels in a manner suggested from some, although not all, experimental studies (Graham et al., 1987; Kovachich et al., 1992; Cheetham et al., 1993; Pineyro et al., 1994; Rattray et al., 1996; Gobbi et al., 1997; Benmansour et al., 1999; Horschitz et al., 2001; Benmansour et al., 2002; Evrard et al., 2002; Gould et al., 2003 Gould et al., , 2006 Rothman et al., 2003) , our observation of an inverted U-shaped relation between 5-HT 2A receptor and SERT binding may be the result of inter-individual differences in cerebral baseline 5-HT levels.
So far, only one study has examined the relationship between postsynaptic 5-HT receptor and SERT binding in the human brain previously. In 12 healthy individuals, Lundberg et al. (2007) investigated both the 5-HT 1A receptor binding and SERT binding with PET. They found a positive correlation between the two markers in the raphe nuclei and in the hippocampus but not in the frontal cortex. The positive correlation in raphe is not unexpected because both markers exhibit proportionality to the number of serotonergic neurons. Based on animal studies (Le Poul et al., 1995; Cahir et al., 2007; Riad et al., 2008) , however, the anticipation would be an inverted U-shaped relationship between 5-HT 1A receptor and SERT binding in hippocampus and frontal cortex, because 5-HT 1A receptor levels seem to be relatively resistant to changes in cerebral 5-HT levels. The authors did not attempt to model an inverted U-formed relationship, and the relatively low sample size may also have been prohibitive for a more extensive analysis.
A potential confound with our study is that, in some individuals, there was an interval of more than 2 years between the two PET acquisitions. We have, however, in a longitudinal study shown that 5-HT 2A receptor binding remains relatively stable over 2 years . We also ensured that the outcome was the same in the subsample of the cohort that was scanned within 2 weeks and in the full sample. Because we had relatively few individuals with very high 5-HT 2A receptor binding (Fig. 1) , which could have driven the association with SERT, we conducted a post hoc analysis in which we excluded the subjects with the 10% largest BP P values. The quadratic relationship with 5-HT 2A BP P was confirmed for the caudate-putamen-thalamus as well as for the cortical SERT region, whereas the relation was not significant between midbrain SERT BP ND and cortical 5-HT 2A BP P in this subsample. The degree of noise in the latter region might have accounted for this difference.
Apart from a compensatory regulation of the serotonergic markers secondary to differences in cerebral 5-HT levels, alternative interpretations should also be considered. Instead of cerebral 5-HT level being the primary regulator of the two markers, SERT or 5-HT 2A receptors may also both independently regulate the levels of the other marker.
Thus, primary differences in the cerebral SERT levels, caused by either genetic or environmental factors, do influence cerebral 5-HT levels, and this could then in turn regulate 5-HT 2A receptor protein levels. By its selective reuptake of 5-HT, SERT is the key regulator of the synaptic levels of this transmitter. For example, the short allele of the SCL6A4 serotonin transporter-linked polymorphic region (5-HTTLPR) polymorphism confers decreased SERT expression (Lesch et al., 1996; Little et al., 1998; Heinz et al., 2000) and binding, especially when taking the triallelic variation in the 5-HTTLPR into account (Praschak-Rieder et al., 2007; Reimold et al., 2007) , although conflicting data exist (Greenberg et al., 1999; Mann et al., 2000; Preuss et al., 2000; van Dyck et al., 2004; Parsey et al., 2006) . Currently, there are no published studies available to address whether the SCL6A4 5-HTTLPR polymorphism or other functional SERT polymorphisms have any impact on cerebral 5-HT 2A receptor binding in humans. A number of studies do, however, investigate 5-HT 2A receptor levels in transgenic mice that either underexpress or overexpress SERT. SERT knock-out mice have a sixfold increase in extracellular 5-HT (Bengel et al., 1998) , and, in these mice, a 42% decrease is seen in the cortical but not in the striatal 5-HT 2A receptor density (Rioux et al., 1999) . Consistent with this observation, pharmacological stimulation with a 5-HT 2A receptor agonist was associated with a marked attenuation of the head-twitch response and in phospholipase A2 signaling in SERT knock-out compared with SERT overexpressing mice (Qu et al., 2005) . Similarly, in SERT overexpressing mice with decreased extracellular 5-HT levels, increased functional sensitivity of the 5-HT 2A receptor was found; 5-HT 2A receptor agonist stimulation induced a greater increase in both c-Fos and Arc mRNA expression in cortical brain regions and more head twitches compared with wild-type mice (Jennings et al., 2008) , although the authors were unable to demonstrate significantly increased 5-HT 2A receptor binding. Based on these studies, it is not possible to assess the independent role of cerebral SERT levels and function versus that of 5-HT levels on cortical 5-HT 2A receptor levels, but we consider it more likely that the alterations in 5-HT 2A receptor levels and function are generated through changes in 5-HT levels.
Last, the possibility of the 5-HT 2A receptor as the primary site of regulation should also be considered: stimulation of this receptor causes a decrease in the firing of raphe nuclei 5-HT neurons (Boothman et al., 2003 ) through a negative feedback possibly mediated by glutamatergic projections from cortex to raphe GABA interneurons (Sharp et al., 2007) . A high level of 5-HT 2A receptor activity could therefore potentially decrease 5-HT neuron firing from raphe nuclei and thus, through decreased 5-HT release, and lower subcortical and cortical SERT levels, but it does not fully explain the observed inverted U-formed association.
In conclusion, the observed regional intercorrelation for both 5-HT 2A receptor and SERT cerebral binding suggests that, within the single individual, each marker has a set point adjusted through a common regulator. We suggest that this regulator could be extracellular 5-HT levels and, accordingly, that 5-HT levels vary between individuals, depending on genetic and/or environmental influence.
